Business
Myomo Reports First Quarter 2025 Financial and Operating Results
BURLINGTON, Mass., May 07, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.
About this update from Myomo Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":898,"height":230,"url":"https://media.zenfs.com/en/business-wire.com/78d5a54e5ca4fef191daa57d126a184f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/G27ds4Qi5vvoG2bxj8o_.Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/78d5a54e5ca4fef191daa57d126a184f","width":898,"height":230},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/TmesWkER.7Rsa2tzKyzlAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE3OTY7aD00NjA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/78d5a54e5ca4fef191daa57d126a184f","width":898,"height":230}},"lazy":false},{"type":"text","content":"Revenue of $9.8 millionRecord 700 patients added to the pipelineMore than 300 Certified Prosthetists Orthotists have completed initial MyoPro® training","length":153,"tagName":"p","attribs":{}},{"type":"text","content":"Conference call being held today at 4:30pm Eastern time","length":55,"tagName":"p","attribs":{}},{"type":"text","content":"BURLINGTON, Mass., May 07, 2025--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.","length":352,"tagName":"p"},{"type":"text","content":"Financial and operating highlights for the first quarter of 2025 include the following (all comparisons are with the first quarter of 2024 unless otherwise indicated):","length":167,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $9.8 million, up 162%;","length":34,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Revenue units were 182, up 100%; 45% of revenue units were from first quarter authorizations and orders","length":103,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Medicare Part B patients represented 59% of first quarter 2025 revenue;","length":71,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Orders and insurance authorizations were received for 213 MyoPro units, up 18%;","length":79,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Backlog, which represe...